Evaluation of the SharkCore^® needle for EUS-guided core biopsy of pancreatic neuroendocrine tumors

Abstract

Our pilot investigation targeting patients with known or suspected pancreatic NETs indicates that the SharkCore^® needle shows promise in obtaining suitable tissue for ancillary testing that can allow for more definitive pathologic interpretations on EUS FNA specimens. Fewer passes were needed with the core needle when compared to a standard needle.